Logo
DCA

Becton, Dickinson and Company

sp500
BDXHealthcareMedical Instruments & Supplies
144,43 $US
-0.62%
Dernier cours
144,43 $US
2026-06-02
Variation 24h
-0.62%
-0.90 USD
Volume
2,1 M
Titres échangés
Fiabilité des données
Forte
13433 points (53 ans)

Évolution du cours

Lancer une simulation avec cet actif

BDX

Paramètres globaux

Données disponibles du 21/02/1973 au 02/06/2026

Analyse Fondamentale

New
CAGR (5y)
4.99%
Revenue Growth
Net Margin
7.68%
Profitability
ROE
6.61%
Return on Equity
Debt / EBITDA
3.87
Solvency
PEG Ratio
1.15
Valuation vs Growth
Rev. Growth (TTM)
1.60%
Current Trend

Historique PER (5 ans)

Historical PE
Average (40.0x)
Current: 24.4x
Focus technique
BDX
Volatilité 30j
26.04%
Écart MA50
-4.41%
Écart MA200
-19.60%
Écart ATH
-49.07%
Momentum 3M
-15.78%
Score de risque
N/A

Volatilité modérée. Momentum neutre.

À propos de Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Investir cet actif
Acheter via Saxo Banque
🏦Courtier régulé (AMF)
🌍Accès marchés globaux
📈Outils professionnels

Lien commercial. Investir comporte des risques.

Analyse Technique & Risque

Metrics Clés

CAGR8.11%
Volatilité26.04%
Max Drawdown-49.80%

Momentum : BDX

Indicateur synthétique
PEURNEUTREAVIDITÉ
40
Fear

Analyse Risque

VaR (95%)-2.39%
Santé DCA
86/100

Historique récent (60 jours)

DateClôtureVolume
2026-06-02144,43 $US2 085 837
2026-06-01145,33 $US2 353 996
2026-05-29147,12 $US3 658 099
2026-05-28148,41 $US2 456 040
2026-05-27147,24 $US2 878 200
2026-05-26147,75 $US3 243 481
2026-05-22147,63 $US1 004 167
2026-05-21146,25 $US1 574 560
2026-05-20146,95 $US2 057 077
2026-05-19146,95 $US3 053 565
2026-05-18142,35 $US3 773 030
2026-05-15143,47 $US4 277 310
2026-05-14144,47 $US2 319 158
2026-05-13144,18 $US3 650 067
2026-05-12147,51 $US3 465 234
2026-05-11143,15 $US3 378 688
2026-05-08149,43 $US4 019 734
2026-05-07153,26 $US5 132 482
2026-05-06144,76 $US3 399 234
2026-05-05144,17 $US2 810 660
2026-05-04146,31 $US1 925 651
2026-05-01149,31 $US1 818 077
2026-04-30149,04 $US1 943 949
2026-04-29145,31 $US2 917 648
2026-04-28149,52 $US2 094 893
2026-04-27150,22 $US2 681 313
2026-04-24152,14 $US1 729 488
2026-04-23154,85 $US2 664 370
2026-04-22155,65 $US1 957 052
2026-04-21156,69 $US3 209 625
2026-04-20158,64 $US3 235 577
2026-04-17158,54 $US2 832 669
2026-04-16154,82 $US3 372 109
2026-04-15155,52 $US2 013 286
2026-04-14155,73 $US2 338 838
2026-04-13155,43 $US2 880 880
2026-04-10154,22 $US1 694 892
2026-04-09155,46 $US1 995 252
2026-04-08157,09 $US2 186 904
2026-04-07154,96 $US1 365 096
2026-04-06155,32 $US1 875 904
2026-04-02154,51 $US1 822 914
2026-04-01156,34 $US1 620 945
2026-03-31157,23 $US1 769 376
2026-03-30154,69 $US1 498 843
2026-03-27154,51 $US1 855 730
2026-03-26157,38 $US2 369 969
2026-03-25158,27 $US1 323 500
2026-03-24155,92 $US2 218 350
2026-03-23156,23 $US1 652 406
2026-03-20154,13 $US3 722 926
2026-03-19156,53 $US1 638 944
2026-03-18158,08 $US1 681 443
2026-03-17161,64 $US2 154 435
2026-03-16160,27 $US2 184 032
2026-03-13159,36 $US1 939 747
2026-03-12159,63 $US2 372 988
2026-03-11163,17 $US3 219 144
2026-03-10163,88 $US2 528 200
2026-03-09165,46 $US2 343 646

Derniers Dividendes

DateMontant
2026-03-10+1,05 $US
2025-12-08+1,05 $US
2025-09-08+1,04 $US
2025-06-09+1,04 $US
2025-03-10+1,04 $US
2024-12-09+1,04 $US
2024-09-09+0,95 $US
2024-06-10+0,95 $US
2024-03-07+0,95 $US
2023-12-07+0,95 $US
2023-09-07+0,91 $US
2023-06-08+0,91 $US
2023-03-09+0,91 $US
2022-12-08+0,91 $US
2022-09-08+0,87 $US
2022-06-08+0,87 $US
2022-03-09+0,85 $US
2021-12-09+0,85 $US
2021-09-08+0,81 $US
2021-06-08+0,81 $US

Actifs Relatifs